Research Paper Volume 16, Issue 12 pp 10636—10656
Comprehensive single-cell and bulk RNA-seq analyses reveal a novel CD8+ T cell-associated prognostic signature in ovarian cancer
Figure 6. High/low-risk group patients differ in drug sensitivity and response to immunotherapy. (A) Bubble plot showing the relationship between drugs, risk score, and model genes. (B) Violin plot showing the comparison of IC50 of cisplatin between high/low-risk groups, and scatter plot showing the correlation between the IC50 of drugs and the risk score. (C) Violin plot showing the comparison of IC50 of cyclophosphamide between high/low-risk groups, and scatter plot showing the correlation between the IC50 of drugs and the risk score. (D) Violin plot showing the comparison of IC50 of docetaxel between high/low-risk groups, and scatter plot showing the correlation between the IC50 of drugs and the risk score.